Cadwalader Wickersham & Taft and Covington & Burling have taken the lead roles on Pfizer’s $3.6bn (£2.3bn) acquisition of King Pharmaceuticals, reports The Am Law Daily.

Cadwalader is advising Pfizer, the world’s largest drugmaker, on its takeover of King, a leading provider of pain medications.